Oncolytics schedules FDA meeting on anal cancer drug pathway.
Share this article
Corporate
Score 25
Neutral
Oncolytics schedules FDA meeting on anal cancer drug pathway
Apr 06, 2026 13:09 UTC
ONC, ^GSPC
Short term
Related Articles
Score 65
Nvidia's CoWoS supplies still secured, but Rubin delay issues crop up: KeyBanc
Apr 06, 14:52
Score 35
Bullish
J.P. Morgan Initiates Bullish Outlook for MDA Space Amid Satellite Industry Growth
Apr 06, 14:50
Score 35
BNY Mellon and Robinhood Partner to Launch Trump Accounts App
Apr 06, 14:49
Score 75
Ceasefire Hopes Spark Volatility in Global Markets
Apr 06, 14:46
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.